SGL5213, a novel and potent intestinal SGLT1 inhibitor, suppresses intestinal glucose absorption and enhances plasma GLP-1 and GLP-2 secretion in rats

詳細情報 詳細情報について

• CRID

  1360857596598364032

• DOI

  10.1016/j.ejphar.2019.03.023

• ISSN

  00142999

• Web Site

  https://api.elsevier.com/content/article/PII:S0014299919301785?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0014299919301785?httpAccept=text/plain

• データソース種別

  • Crossref